- Letter: Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2019;43;276-86)
-
Seok H, Sohn TS
- KMID: 2455677
- Diabetes Metab J.
- 2019 Aug;43(4):545-546.
- doi: 10.4093/dmj.2019.0130
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Changes in Metabolic Profile Over Time: Impact on the Risk of Diabetes
-
Cho Y, Lee SH
- KMID: 2455664
- Diabetes Metab J.
- 2019 Aug;43(4):407-409.
- doi: 10.4093/dmj.2019.0141
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Response: Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes metab J 2019;43;276-86)
-
Oh TJ, Choi SH
- KMID: 2455678
- Diabetes Metab J.
- 2019 Aug;43(4):547-548.
- doi: 10.4093/dmj.2019.0148
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- 2019 Clinical Practice Guidelines for Type 2 Diabetes Mellitus in Korea
-
Kim MK, Ko SH, Kim BY, Kang ES, Noh J, Kim SK, Park SO, Hur KY, Chon S, Moon MK, Kim NH, Kim SY, Rhee SY, Lee KW, Kim JH, Rhee EJ, Chun S, Yu SH, Kim DJ, Kwon HS, Park KS, Committee of Clinical Practice Guidelines, Korean Diabetes Association
- KMID: 2455663
- Diabetes Metab J.
- 2019 Aug;43(4):398-406.
- doi: 10.4093/dmj.2019.0137
The Committee of Clinical Practice Guidelines of the Korean Diabetes Association revised and updated the 6th Clinical Practice Guidelines in 2019. Targets of glycemic, blood pressure, and lipid control in... -
- CITED
-
- Close
- SHARE
-
- Close
- Diabetes Fact Sheets in Korea, 2018: An Appraisal of Current Status
-
Kim BY, Won JC, Lee JH, Kim HS, Park JH, Ha KH, Won KC, Kim DJ, Park KS
- KMID: 2455671
- Diabetes Metab J.
- 2019 Aug;43(4):487-494.
- doi: 10.4093/dmj.2019.0067
BACKGROUND: The objective of this study was to investigate the prevalence, management, and comorbidities of diabetes among Korean adults aged 30 years and older. METHODS: This study used 2013 to 2016... -
- CITED
-
- Close
- SHARE
-
- Close
- Continuous Glucose Monitoring Sensors for Diabetes Management: A Review of Technologies and Applications
-
Cappon G, Vettoretti M, Sparacino , Facchinetti A
- KMID: 2455662
- Diabetes Metab J.
- 2019 Aug;43(4):383-397.
- doi: 10.4093/dmj.2019.0121
By providing blood glucose (BG) concentration measurements in an almost continuous-time fashion for several consecutive days, wearable minimally-invasive continuous glucose monitoring (CGM) sensors are revolutionizing diabetes management, and are becoming... -
- CITED
-
- Close
- SHARE
-
- Close
- Additional Effect of Dietary Fiber in Patients with Type 2 Diabetes Mellitus Using Metformin and Sulfonylurea: An Open-Label, Pilot Trial
-
Lee SE, Choi Y, Jun JE, Lee YB, Jin SM, Hur KY, Ko GP, Lee MK
- KMID: 2455666
- Diabetes Metab J.
- 2019 Aug;43(4):422-431.
- doi: 10.4093/dmj.2018.0090
BACKGROUND: Metformin, sulfonylurea, and dietary fiber are known to affect gut microbiota in patients with type 2 diabetes mellitus (T2DM). This open and single-arm pilot trial investigated the effects of... -
- CITED
-
- Close
- SHARE
-
- Close
- Glycosylated Hemoglobin in Subjects Affected by Iron-Deficiency Anemia
-
Intra J, Limonta G, Cappellini F, Bertona M, Brambilla
- KMID: 2455676
- Diabetes Metab J.
- 2019 Aug;43(4):539-544.
- doi: 10.4093/dmj.2018.0072
Previous studies have suggested that iron-deficiency anemia affects glycosylated hemoglobin (HbA1c) measurements, but the results were contradictory. We conducted a retrospective case-control study to determine the effects of iron deficiency... -
- CITED
-
- Close
- SHARE
-
- Close
- Factors Related to Blood Intact Incretin Levels in Patients with Type 2 Diabetes Mellitus
-
Yoo S, Yang EJ, Koh G
- KMID: 2455672
- Diabetes Metab J.
- 2019 Aug;43(4):495-503.
- doi: 10.4093/dmj.2018.0105
BACKGROUND: We performed this study to identify factors related to intact incretin levels in patients with type 2 diabetes mellitus (T2DM). METHODS: We cross-sectionally analyzed 336 patients with T2DM. Intact glucagon-like... -
- CITED
-
- Close
- SHARE
-
- Close
- Effectiveness and Safety of Adding Basal Insulin Glargine in Patients with Type 2 Diabetes Mellitus Exhibiting Inadequate Response to Metformin and DPP-4 Inhibitors with or without Sulfonylurea
-
Kang YM, Jung CH, Lee SH, Kim SW, Song KH, Kim SG, Kim JH, Cho YM, Park TS, Ku BJ, Koh G, Kim DM, Lee BW, Park JY
- KMID: 2455667
- Diabetes Metab J.
- 2019 Aug;43(4):432-446.
- doi: 10.4093/dmj.2018.0092
BACKGROUND: We aimed to investigate the effectiveness and safety of adding basal insulin to initiating dipeptidyl peptidase-4 (DPP-4) inhibitor and metformin and/or sulfonylurea (SU) in achieving the target glycosylated hemoglobin... -
- CITED
-
- Close
- SHARE
-
- Close
- Association between Serum Selenium Level and the Presence of Diabetes Mellitus: A Meta-Analysis of Observational Studies
-
Kim J, Chung HS, Choi MK, Roh YK, Yoo HJ, Park JH, Kim DS, Yu JM, Moon S
- KMID: 2455668
- Diabetes Metab J.
- 2019 Aug;43(4):447-460.
- doi: 10.4093/dmj.2018.0123
BACKGROUND: Epidemiological studies have suggested an association between selenium (Se) and diabetes mellitus (DM). However, different studies have reported conflicting results. Therefore, we performed a comprehensive meta-analysis to clarify the... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of Longitudinal Changes in Metabolic Syndrome Status over 2 Years on 10-Year Incident Diabetes Mellitus
-
Huh JH, Ahn SG, Kim YI, Go T, Sung KC, Choi JH, Koh KK, Kim JY
- KMID: 2455675
- Diabetes Metab J.
- 2019 Aug;43(4):530-538.
- doi: 10.4093/dmj.2018.0111
BACKGROUND: Metabolic syndrome (MetS) is a known predictor of diabetes mellitus (DM), but whether longitudinal changes in MetS status modify the risk for DM remains unclear. We investigated whether changes... -
- CITED
-
- Close
- SHARE
-
- Close
- Lower Leg Fat Depots Are Associated with Albuminuria Independently of Obesity, Insulin Resistance, and Metabolic Syndrome (Korea National Health and Nutrition Examination Surveys 2008 to 2011)
-
Han E, Cho NH, Kim MK, Kim HS
- KMID: 2455669
- Diabetes Metab J.
- 2019 Aug;43(4):461-473.
- doi: 10.4093/dmj.2018.0081
BACKGROUND: Although the involvement of obesity in metabolic disorders is well known, leg fat depot influences on albuminuria have not been determined. METHODS: This population-based, cross-sectional study used a nationally representative... -
- CITED
-
- Close
- SHARE
-
- Close
- The Protective Effects of Increasing Serum Uric Acid Level on Development of Metabolic Syndrome
-
Yu TY, Jin SM, Jee JH, Bae JC, Lee MK, Kim JH
- KMID: 2455673
- Diabetes Metab J.
- 2019 Aug;43(4):504-520.
- doi: 10.4093/dmj.2018.0079
BACKGROUND: It has not been determined whether changes in serum uric acid (SUA) level are associated with incident metabolic syndrome (MetS). The aim of the current study was to investigate... -
- CITED
-
- Close
- SHARE
-
- Close
- Asian Subpopulations May Exhibit Greater Cardiovascular Benefit from Long-Acting Glucagon-Like Peptide 1 Receptor Agonists: A Meta-Analysis of Cardiovascular Outcome Trials
-
Kang YM, Cho YK, Lee J, Lee SE, Lee WJ, Park JY, Kim YJ, Jung CH, Nauck MA
- KMID: 2455665
- Diabetes Metab J.
- 2019 Aug;43(4):410-421.
- doi: 10.4093/dmj.2018.0070
BACKGROUND: Based on reported results of three large cardiovascular outcome trials (CVOTs) of glucagon-like peptide 1 receptor agonists (GLP-1 RAs), we aimed to investigate the overall effect of GLP-1 RAs... -
- CITED
-
- Close
- SHARE
-
- Close
- Plasma Fetuin-A Levels and Risk of Type 2 Diabetes Mellitus in A Chinese Population: A Nested Case-Control Study
-
Wang Y, Koh WP, Jensen MK, Yuan JM, Pan A
- KMID: 2455670
- Diabetes Metab J.
- 2019 Aug;43(4):474-486.
- doi: 10.4093/dmj.2018.0171
BACKGROUND: Fetuin-A is a hepatokine that involved in the pathogenesis of insulin resistance. Previous epidemiological studies have found a positive association between blood fetuin-A and type 2 diabetes mellitus (T2DM)... -
- CITED
-
- Close
- SHARE
-
- Close
- Increased Serum Angiopoietin-Like 6 Ahead of Metabolic Syndrome in a Prospective Cohort Study
-
Namkung J, Sohn JH, Chang JS, Park SW, Kim JY, Koh SB, Kong ID, Park KS
- KMID: 2455674
- Diabetes Metab J.
- 2019 Aug;43(4):521-529.
- doi: 10.4093/dmj.2018.0080
BACKGROUND: Despite being an anti-obesity hepatokine, the levels of serum angiopoietin-like 6 (ANGPTL6) are elevated in various metabolic diseases. Thus, ANGPTL6 expression may reflect metabolic burden and may have compensatory... -
- CITED
-
- Close
- SHARE
-
- Close
